Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Information Services Group, Inc. stock logo
III
Information Services Group
$5.21
+4.2%
$4.66
$2.95
$5.28
$241.02M1.21122,285 shs324,118 shs
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$2.22
+2.3%
$2.30
$2.00
$5.20
$230.92M1.23610,112 shs648,374 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$13.69
+4.9%
$12.37
$3.78
$15.71
$241.36M1.34300,819 shs173,451 shs
Phunware stock logo
PHUN
Phunware
$3.52
+8.0%
$3.11
$2.22
$14.60
$65.76M2.342.26 million shs375,550 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Information Services Group, Inc. stock logo
III
Information Services Group
+4.20%+8.54%+8.09%+44.32%+73.09%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
+2.30%+2.30%+3.26%-12.25%-45.19%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
+4.90%+0.74%-6.36%+65.14%+37.45%
Phunware stock logo
PHUN
Phunware
+7.98%+10.34%+8.98%+30.37%-38.68%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Information Services Group, Inc. stock logo
III
Information Services Group
2.3506 of 5 stars
1.53.01.70.01.92.51.9
MaxCyte, Inc. stock logo
MXCT
MaxCyte
2.6252 of 5 stars
3.53.00.00.00.01.70.6
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
1.2588 of 5 stars
2.41.00.00.02.51.70.6
Phunware stock logo
PHUN
Phunware
1.8002 of 5 stars
3.31.00.00.02.30.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Information Services Group, Inc. stock logo
III
Information Services Group
3.00
Buy$5.505.57% Upside
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.00
Buy$7.50237.84% Upside
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
2.73
Moderate Buy$10.81-21.02% Downside
Phunware stock logo
PHUN
Phunware
2.50
Moderate Buy$6.6789.39% Upside

Current Analyst Ratings Breakdown

Latest PHUN, OPRX, MXCT, and III Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.50 ➝ $16.00
6/6/2025
Phunware stock logo
PHUN
Phunware
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $12.50
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $12.50
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$11.00 ➝ $14.00
5/12/2025
Information Services Group, Inc. stock logo
III
Information Services Group
Sidoti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/12/2025
Information Services Group, Inc. stock logo
III
Information Services Group
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$3.75 ➝ $5.50
4/21/2025
Phunware stock logo
PHUN
Phunware
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $12.00
(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Information Services Group, Inc. stock logo
III
Information Services Group
$247.59M1.01$0.24 per share22.06$1.96 per share2.66
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$38.63M6.12N/AN/A$1.95 per share1.14
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$92.13M2.75N/AN/A$6.35 per share2.16
Phunware stock logo
PHUN
Phunware
$3.19M22.26N/AN/A$5.31 per share0.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Information Services Group, Inc. stock logo
III
Information Services Group
$2.84M$0.1534.7332.561.443.18%7.10%3.13%8/4/2025 (Estimated)
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$41.06M-$0.40N/AN/AN/A-110.92%-19.90%-17.24%8/5/2025 (Estimated)
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-$18.66M-$0.84N/AN/A4.35-16.33%-0.29%-0.20%8/6/2025 (Estimated)
Phunware stock logo
PHUN
Phunware
-$10.32M-$0.81N/AN/AN/A-397.39%-16.61%-14.50%8/14/2025 (Estimated)

Latest PHUN, OPRX, MXCT, and III Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025N/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.10N/AN/AN/A$9.57 millionN/A
8/4/2025Q2 2025
Information Services Group, Inc. stock logo
III
Information Services Group
$0.07N/AN/AN/A$59.98 millionN/A
5/12/2025Q1 2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-$0.11$0.08+$0.19-$0.12$18.69 million$21.93 million
5/12/2025Q1 2025
Phunware stock logo
PHUN
Phunware
-$0.12-$0.12N/A-$0.18$0.60 million$0.69 million
5/7/2025Q1 2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.10-$0.10N/A-$0.10$9.05 million$10.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Information Services Group, Inc. stock logo
III
Information Services Group
$0.183.45%N/A120.00%1 Years
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/AN/AN/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
Phunware stock logo
PHUN
Phunware
N/AN/AN/AN/AN/A

Latest PHUN, OPRX, MXCT, and III Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2025
Information Services Group, Inc. stock logo
III
Information Services Group
quarterly$0.04503.9%6/6/20256/6/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Information Services Group, Inc. stock logo
III
Information Services Group
0.62
2.42
2.42
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/A
12.23
11.58
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
0.25
2.82
2.82
Phunware stock logo
PHUN
Phunware
0.01
15.40
15.41

Institutional Ownership

CompanyInstitutional Ownership
Information Services Group, Inc. stock logo
III
Information Services Group
73.10%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
68.81%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
76.47%
Phunware stock logo
PHUN
Phunware
7.57%

Insider Ownership

CompanyInsider Ownership
Information Services Group, Inc. stock logo
III
Information Services Group
15.90%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.30%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
5.60%
Phunware stock logo
PHUN
Phunware
0.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Information Services Group, Inc. stock logo
III
Information Services Group
1,32348.20 million40.54 millionNot Optionable
MaxCyte, Inc. stock logo
MXCT
MaxCyte
80106.42 million102.90 millionOptionable
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
10018.50 million17.46 millionOptionable
Phunware stock logo
PHUN
Phunware
12020.17 million20.11 millionOptionable

Recent News About These Companies

Phunware (NASDAQ:PHUN) Shares Down 5.2% - Here's Why
Phunware price target lowered to $4.50 from $20 at Roth MKM
Phunware Reports Full Year 2024 Financial Results
Phunware Appoints Quyen Du to Board of Directors
Phunware appoints Krol as Chief Operating Officer
NOTICE TO DISREGARD -- Phunware, Inc.
Phunware announces deployment of Smart Hospitality to JW Marriott Phoenix

New MarketBeat Followers Over Time

Media Sentiment Over Time

Information Services Group stock logo

Information Services Group NASDAQ:III

$5.21 +0.21 (+4.20%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$5.27 +0.06 (+1.13%)
As of 07/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX to automate the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management; ISG Generative AI; ISG Network Select to streamline and simplify how enterprises build their network solutions; HR technology and transformations; providers-as-a-business services; ISG Digital Engineering; ISG Research; and training-as-a-service. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.

MaxCyte stock logo

MaxCyte NASDAQ:MXCT

$2.22 +0.05 (+2.30%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.31 +0.09 (+4.10%)
As of 05:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$13.69 +0.64 (+4.90%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$13.90 +0.21 (+1.53%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Phunware stock logo

Phunware NASDAQ:PHUN

$3.52 +0.26 (+7.98%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$3.53 +0.01 (+0.28%)
As of 05:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Phunware, Inc., together with its subsidiaries, provides integrated software platform that equips companies with the products, solutions, and services to engage, manage, and monetize their mobile application portfolios in the United States and internationally. The company's products and services include mobile software and application transaction solutions comprise integration of software development kit (SDK) licenses, which consists of analytics that offers data related to application use and engagement; content management that allows application administrators to create and manage app content in a cloud-based portal; alerts, notifications, and messaging, which enables brands to send messages; marketing automation that enables location-triggered messages and workflow; advertising; and location-based services, such as mapping, navigation, wayfinding, workflow, asset management, and policy enforcement. It is also involved in the integration of its SDK licenses into existing applications maintained by its customers, as well as custom application development and support services; and provision of cloud-based vertical solutions for healthcare, retail, sports, aviation, real estate, hospitality, education, and other applications, as well as application transactions, including re-occurring and one-time transactional media purchases for application discovery, user acquisition and audience building, audience engagement, and audience monetization. Phunware, Inc. was founded in 2009 and is headquartered in Austin, Texas.